This company is a leading manufacturer of vaccines and immuno-biologicals, with a strong global presence in regions like the EU and North America. They specialize in a range of products including measles, mumps, rubella (MMR) vaccines, diphtheria, tetanus, and pertussis (DTP) vaccines, as well as hepatitis and influenza vaccines. Their product portfolio also extends to malaria vaccines, reflecting their commitment to addressing global health challenges. The company holds GMP certifications and has a proven track record of innovation, evidenced by its development of novel vaccines like the R21/Matrix-M™ Malaria Vaccine. They are actively involved in research and development, constantly expanding their product pipeline to address emerging infectious diseases and improve global health outcomes.

Established in 1982, this manufacturer specializes in veterinary and human vaccines, producing over 150 products. As a CTD dossier owner and manufacturer, it holds WHO-GMP and ISO 9001 certifications, ensuring compliance with international quality standards. The manufacturer operates advanced production lines adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in more than 50 countries worldwide. With a focus on innovation and quality, the manufacturer is committed to delivering effective healthcare solutions.

 

 

 

 

Established in 1982, this manufacturer specializes in veterinary and human vaccines, producing over 150 products. As a CTD dossier owner and manufacturer, it holds WHO-GMP and ISO 9001 certifications, ensuring compliance with international quality standards. The manufacturer operates advanced production lines adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in more than 50 countries worldwide. With a focus on innovation and quality, the manufacturer is committed to delivering effective healthcare solutions.